MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/qad.0000000000004250

Медицинская библиотека · AIDS (London, England) · 2025

Metabolic dysfunction-associated steatotic liver disease was associated with liver fibrosis in people with HIV from Brazil.

Fittipaldi Juliana, Cardoso Sandra W, Nunes Estevão Portela, De Almeida Cristiane Fonseca, De Brito Patricia Dias, Veloso Valdilea G, Grinsztejn Beatriz, Perazzo Hugo

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

To describe the association of metabolic dysfunction-associated steatotic liver disease (MASLD) with clinically significant liver fibrosis (CSLF) in people with HIV from Rio de Janeiro (Brazil).

DESIGN

Cross-sectional study.

METHODS

We analyzed data from the baseline visit of the PROSPEC-HIV-study (NCT02542020). People with HIV aged ≥18 years were submitted to clinical evaluation, questionnaires, blood sample and transient elastography (TE) at INI/FIOCRUZ from June/2015 to March/2019. Exclusion criteria were unreliable TE or missing data. Steatosis and liver fibrosis were assessed by controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) from TE, respectively. MASLD was determined by presence of steatosis (TE-CAP ≥ 263 dB/m) with at least one cardiometabolic-risk-factor (overweight/obesity, diabetes, hypertension or dyslipidemia) without hazard alcohol intake. CSLF was defined by TE-LSM ≥8.0 kPa. Multivariate logistic regression models were performed.

RESULTS

684 participants [47.8% male, median age= 45 [interquartile range (IQR), 36-53] years, 12% with diabetes and 13% with viral hepatitis coinfection] were included. The prevalence [95% confidence interval (CI)] of MASLD and CSLF were 19.3% [16.5-22.4] and 14.2% [11.8-17.0], respectively. In the multivariate analysis [odds ratio (OR) (95% CI)], older age [1.52 (1.75-1.96)], MASLD [2.20 (1.25-3.87)], viral hepatitis [4.93 (2.72-8.94)], higher ALT levels [1.11 (1.04-1.18)] and CD4 + cell count <350 cells/mm 3 [1.95 (1.07-3.53)] were significantly associated with presence of CSLF. MASLD remained independently associated with CSLF in people with HIV mono-infection ( n  = 595) [OR = 2.18 (95% CI, 1.19-3.98)].

CONCLUSION

MASLD increased the odds of CSLF in people with HIV independently of viral hepatitis. Strategies to screen MASLD in are of paramount importance to reduce the burden of liver disease in people with HIV.

Для цитирования: Fittipaldi Juliana, Cardoso Sandra W, Nunes Estevão Portela, De Almeida Cristiane Fonseca, De Brito Patricia Dias, Veloso Valdilea G, Grinsztejn Beatriz, Perazzo Hugo. Metabolic dysfunction-associated steatotic liver disease was associated with liver fibrosis in people with HIV from Brazil.. AIDS (London, England). 2025. DOI: 10.1097/qad.0000000000004250.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.